The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
The diagnosis and treatment of hepatocellular carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Lo, C.-M., Ngan, H., Tso, W.-K., Liu, C.-L., Lam, C.-M., Poon, R. T.-P., Fan, S.-T., & Wong, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33156 · Cited by 2,613
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
Llovet, J. M., Di Bisceglie, A. M., Bruix, J., Kramer, B. S., Lencioni, R., Zhu, A. X., Sherman, M., Schwartz, M., Lotze, M., Talwalkar, J., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn134 · Cited by 1,653
Lammer, J., Malagari, K., Vogl, T., Pilleul, F., Denys, A., Watkinson, A., Pitton, M., Sergent, G., Pfammatter, T., Terraz, S., et al. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9711-7 · Cited by 1,557
Randomized controlled trial of screening for hepatocellular carcinoma
Zhang, B.-H., Yang, B.-H., & Tang, Z.-Y. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0552-0 · Cited by 1,496
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Forner, A., Reig, M. E., Rodriguez de Lope, C., & Bruix, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247133 · Cited by 1,110
Clavien, P.-A., Lesurtel, M., Bossuyt, P. M., Gores, G. J., Langer, B., & Perrier, A. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70175-9 · Cited by 1,026
Ryerson, A. B., Eheman, C. R., Altekruse, S. F., Ward, J. W., Jemal, A., Sherman, R. L., Henley, S. J., Holtzman, D., Lake, A., Noone, A., et al. (2016) · Cancer · doi:10.1002/cncr.29936 · Cited by 945
Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., Garcia-Pagan, J., Visa, J., Bru, C., & Rodes, J. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70070-7 · Cited by 895
Jonas, S., Bechstein, W. O., Steinmüller, T., Herrmann, M., Radke, C., Berg, T., Settmacher, U., & Neuhaus, P. (2001) · Hepatology · doi:10.1053/jhep.2001.23561 · Cited by 894
Resection and Liver Transplantation for Hepatocellular Carcinoma
Llovet, J. M., Schwartz, M., & Mazzaferro, V. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871198 · Cited by 879
One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years
Imamura, H. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.11.1198 · Cited by 835
Ishizawa, T., Hasegawa, K., Aoki, T., Takahashi, M., Inoue, Y., Sano, K., Imamura, H., Sugawara, Y., Kokudo, N., & Makuuchi, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.091 · Cited by 754
Extrahepatic Metastases of Hepatocellular Carcinoma
Katyal, S., Oliver, J. H., Peterson, M. S., Ferris, J. V., Carr, B. S., & Baron, R. L. (2000) · Radiology · doi:10.1148/radiology.216.3.r00se24698 · Cited by 742
Trevisani, F., D'Intino, P. E., Morselli-Labate, A. M., Mazzella, G., Accogli, E., Caraceni, P., Domenicali, M., De Notariis, S., Roda, E., & Bernardi, M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00053-2 · Cited by 731
Simplified Staging for Hepatocellular Carcinoma
Vauthey, J. N., Lauwers, G. Y., Esnaola, N. F., Do, K.-A., Belghiti, J., Mirza, N., Curley, S. A., Ellis, L. M., Regimbeau, J.-M., Rashid, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1527 · Cited by 700
Lok, A. S., Seeff, L. B., Morgan, T. R., di Bisceglie, A. M., Sterling, R. K., Curto, T. M., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.014 · Cited by 651
Salem, R., Lewandowski, R. J., Kulik, L., Wang, E., Riaz, A., Ryu, R. K., Sato, K. T., Gupta, R., Nikolaidis, P., Miller, F. H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.049 · Cited by 650
Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?
El-Serag, H. B., & Kanwal, F. (2014) · Hepatology · doi:10.1002/hep.27222 · Cited by 646
Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort†
Marrero, J. A., Fontana, R. J., Barrat, A., Askari, F., Conjeevaram, H. S., Su, G. L., & Lok, A. S. (2005) · Hepatology · doi:10.1002/hep.20636 · Cited by 637
Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort Study
Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hürter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W., et al. (1998) · Hepatology · doi:10.1002/hep.510280632 · Cited by 636
Yuen, M.-F., Tanaka, Y., Fong, D. Y.-T., Fung, J., Wong, D. K.-H., Yuen, J. C.-H., But, D. Y.-K., Chan, A. O.-O., Wong, B. C.-Y., Mizokami, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.023 · Cited by 584
Poon, R. T.-P., Fan, S.-T., Lo, C.-M., Liu, C.-L., & Wong, J. (1999) · Annals of Surgery · doi:10.1097/00000658-199902000-00009 · Cited by 550
Silva, M. A., Hegab, B., Hyde, C., Guo, B., Buckels, J. A. C., & Mirza, D. F. (2008) · Gut · doi:10.1136/gut.2008.149062 · Cited by 536
(2000) · Hepatology · doi:10.1053/he.2000.5628 · Cited by 521
Uka, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i3.414 · Cited by 477
Diagnostic and Prognostic Role of alpha-Fetoprotein in Hepatocellular Carcinoma: Both or Neither?
Farinati, F., Marino, D., Giorgio, M. D., Baldan, A., Cantarini, M. C., Cursaro, C., Rapaccini, G., Poggio, P. D., Nolfo, M. A. D., Benvegnù, L., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00443.x · Cited by 458
Prospective validation of the Barcelona Clinic Liver Cancer staging system
Cillo, U., Vitale, A., Grigoletto, F., Farinati, F., Brolese, A., Zanus, G., Neri, D., Boccagni, P., Srsen, N., D'Amico, F., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.015 · Cited by 425
Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes
Shah, S. A., Cleary, S. P., Wei, A. C., Yang, I., Taylor, B. R., Hemming, A. W., Langer, B., Grant, D. R., Greig, P. D., & Gallinger, S. (2007) · Surgery · doi:10.1016/j.surg.2006.06.028 · Cited by 420
Gupta, S., Bent, S., & Kohlwes, J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00012 · Cited by 420
Early Hepatocellular Carcinoma As An Entity With A High Rate of Surgical Cure
Takayama, T., Makuuchi, M., Hirohashi, S., Sakamoto, M., Yamamoto, J., Shimada, K., Kosuge, T., Okada, S., Takayasu, K., & Yamasaki, S. (1998) · Hepatology · doi:10.1002/hep.510280511 · Cited by 388
Marrero, J. A., Kudo, M., Venook, A. P., Ye, S.-L., Bronowicki, J.-P., Chen, X.-P., Dagher, L., Furuse, J., Geschwind, J.-F. H., de Guevara, L. L., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.020 · Cited by 385
Llovet, J. M., Bruix, J., Fuster, J., Castells, A., Garcia-Valdecasas, J. C., Grande, L., França, A., Brú, C., Navasa, M., Ayuso, M. D., et al. (1998) · Hepatology · doi:10.1002/hep.510270616 · Cited by 382
Brown, K. T., Do, R. K., Gonen, M., Covey, A. M., Getrajdman, G. I., Sofocleous, C. T., Jarnagin, W. R., D’Angelica, M. I., Allen, P. J., Erinjeri, J. P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0821 · Cited by 380
Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
SUNG, J. J. Y., TSOI, K. K. F., WONG, V. W. S., LI, K. C. T., & CHAN, H. L. Y. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03816.x · Cited by 370
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach
Cammà, C., Giunta, M., Andreone, P., & Craxı̀, A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00005-8 · Cited by 356
Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
Tandon, P., & Garcia‐Tsao, G. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01957.x · Cited by 354
Grazi, G. L., Ercolani, G., Pierangeli, F., Del Gaudio, M., Cescon, M., Cavallari, A., & Mazziotti, A. (2001) · Annals of Surgery · doi:10.1097/00000658-200107000-00011 · Cited by 341
Chen, J., Yang, H., Iloeje, U. H., You, S., Lu, S., Wang, L., Su, J., Sun, C., Liaw, Y., & Chen, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.042 · Cited by 331
Livraghi, T., Solbiati, L., Meloni, F., Ierace, T., Goldberg, S. N., & Gazelle, G. S. (2003) · Cancer · doi:10.1002/cncr.11426 · Cited by 329
Stigliano, R., Marelli, L., Yu, D., Davies, N., Patch, D., & Burroughs, A. K. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.04.001 · Cited by 311
Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma
Zhou, X.-D., Tang, Z.-Y., Yang, B.-H., Lin, Z.-Y., Ma, Z.-C., Ye, S.-L., Wu, Z.-Q., Fan, J., Qin, L.-X., & Zheng, B.-H. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8<1479::aid-cncr1155>3.0.co;2-0 · Cited by 302
Tangkijvanich, P., Anukulkarnkusol, N., Suwangool, P., Lertmaharit, S., Hanvivatvong, O., Kullavanijaya, P., & Poovorawan, Y. (2000) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200012000-00007 · Cited by 298
Cucchetti, A., Ercolani, G., Vivarelli, M., Cescon, M., Ravaioli, M., La Barba, G., Zanello, M., Grazi, G. L., & Pinna, A. D. (2006) · Liver Transplantation · doi:10.1002/lt.20761 · Cited by 296
Predictors and patterns of recurrence after resection of hepatocellular carcinoma
Cha, C., Fong, Y., Jarnagin, W. R., Blumgart, L. H., & DeMatteo, R. P. (2003) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2003.07.003 · Cited by 281
Hameed, B., Mehta, N., Sapisochin, G., Roberts, J. P., & Yao, F. Y. (2014) · Liver Transplantation · doi:10.1002/lt.23904 · Cited by 279
Cherqui, D., Laurent, A., Mocellin, N., Tayar, C., Luciani, A., Van Nhieu, J. T., Decaens, T., Hurtova, M., Memeo, R., Mallat, A., et al. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181bd582b · Cited by 278
Kew, M. C. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.01.005 · Cited by 275
Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy
Wiesner, R. H., Freeman, R. B., & Mulligan, D. C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.040 · Cited by 273
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems
Liu, P.-H., Hsu, C.-Y., Hsia, C.-Y., Lee, Y.-H., Su, C.-W., Huang, Y.-H., Lee, F.-Y., Lin, H.-C., & Huo, T.-I. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.029 · Cited by 263
Yoo, H. Y., Patt, C. H., Geschwind, J.-F., & Thuluvath, P. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.137 · Cited by 248
Grieco, A., Pompili, M., Caminiti, G., Miele, L., Covino, M., Alfei, B., Rapaccini, G. L., & Gasbarrini, G. (2005) · Gut · doi:10.1136/gut.2004.048124 · Cited by 242
Ng, K. K., Vauthey, J.-N., Pawlik, T. M., Lauwers, G. Y., Regimbeau, J.-M., Belghiti, J., Ikai, I., Yamaoka, Y., Curley, S. A., Nagorney, D. M., et al. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.06.004 · Cited by 241
Liver transplantation for hepatocellular carcinoma: The MELD impact
Sharma, P., Balan, V., Hernandez, J. L., Harper, A. M., Edwards, E. B., Rodriguez-Luna, H., Byrne, T., Vargas, H. E., Mulligan, D., Rakela, J., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20012 · Cited by 238
Pawlik, T. M., Poon, R. T., Abdalla, E. K., Ikai, I., Nagorney, D. M., Belghiti, J., Kianmanesh, R., Oi-Lin Ng, I., Curley, S. A., Yamaoka, Y., et al. (2005) · Surgery · doi:10.1016/j.surg.2004.12.012 · Cited by 235
Familial Risk of Hepatocellular Carcinoma Among Chronic Hepatitis B Carriers and Their Relatives
Yu, M.-W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1159 · Cited by 235
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07236-5 · Cited by 230
Pawlik, T. M. (2005) · Archives of Surgery · doi:10.1001/archsurg.140.5.450 · Cited by 224
Benvegnù, L. (1998) · Padua Research Archive (University of Padova) · Cited by 221
Shetty, K., Timmins, K., Brensinger, C., Furth, E. E., Rattan, S., Sun, W., Rosen, M., Soulen, M., Shaked, A., Reddy, R. K., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20140 · Cited by 219
Borzio, M., Fargion, S., Borzio, F., Fracanzani, A. L., Croce, A. M., Stroffolini, T., Oldani, S., Cotichini, R., & Roncalli, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00190-9 · Cited by 199
Yang, L.-Y., Fang, F., Ou, D.-P., Wu, W., Zeng, Z.-J., & Wu, F. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181904988 · Cited by 192
Kamiyama, T., Nakanishi, K., Yokoo, H., Kamachi, H., Tahara, M., Yamashita, K., Taniguchi, M., Shimamura, T., Matsushita, M., & Todo, S. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2010.06.005 · Cited by 188
Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis
Pinter, M., Sieghart, W., Graziadei, I., Vogel, W., Maieron, A., Königsberg, R., Weissmann, A., Kornek, G., Plank, C., & Peck-Radosavljevic, M. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0191 · Cited by 178
Vincenzi, B., Santini, D., Russo, A., Addeo, R., Giuliani, F., Montella, L., Rizzo, S., Venditti, O., Frezza, A. M., Caraglia, M., et al. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0143 · Cited by 176
Berry, K., & Ioannou, G. N. (2013) · Liver Transplantation · doi:10.1002/lt.23652 · Cited by 171
Utsunomiya, T., Shimada, M., Kudo, M., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000821 · Cited by 165
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
Samuel, M., Chow, P. K. H., Shih‐Yen, E. C., Machin, D., & Soo, K. C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001199.pub2 · Cited by 158
Vitale, A., Morales, R., Zanus, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70144-9 · Cited by 156
Pandey, D., Lee, K.-H., Wai, C. T., Wagholikar, G. D., & Tan, K. C. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9518-1 · Cited by 133
Molmenti, E. P., & Klintmalm, G. B. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.34879 · Cited by 123
Cho, Y. K., Chung, J. W., Kim, J. K., Ahn, Y. S., Kim, M. Y., Park, Y. O., Kim, W., & Byun, J. H. (2007) · Cancer · doi:10.1002/cncr.23185 · Cited by 119
Brain metastases from hepatocellular carcinoma: prognostic factors and outcome
Choi, H. J., Cho, B. C., Sohn, J., Shin, S. J., Kim, S. H., Kim, J. H., & Yoo, N. C. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9713-3 · Cited by 116
Wang, Y., Wang, P., Wang, B., Fu, Z., Zhao, W., & Yan, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095485 · Cited by 114
Andreou, A., Vauthey, J., Cherqui, D., Zimmitti, G., Ribero, D., Truty, M. J., Wei, S. H., Curley, S. A., Laurent, A., Poon, R. T. P., et al. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2005-4 · Cited by 112
Tanaka, H., Tsukuma, H., Kasahara, A., Hayashi, N., Yoshihara, H., Masuzawa, M., Kanda, T., Kashiwagi, T., Inoue, A., Kato, M., et al. (2000) · International Journal of Cancer · Cited by 110
Yoon, K. T., Kim, J. K., Kim, D. Y., Ahn, S. H., Lee, J.-D., Yun, M., Rha, S. Y., Chon, C. Y., & Han, K. (2007) · Oncology · doi:10.1159/000111715 · Cited by 105
Xiaohong, S., Li, H., Feng, W., Zhang, T., Yunlong, C., & Li, Q. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0400-0 · Cited by 79
Kim, H. J., Kim, C. Y., Park, E. K., Hur, Y. H., Koh, Y. S., Kim, H. J., & Cho, C. K. (2014) · HPB · doi:10.1111/hpb.12295 · Cited by 73
Hwang, S., Ha, T., Song, G., Jung, D., Ahn, C., Moon, D., Kim, K., Lee, Y. J., & Lee, S. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2846-8 · Cited by 66
Current systemic treatment of hepatocellular carcinoma: A review of the literature
Chen, K.-W. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i10.1412 · Cited by 64
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma
Charrière, B., Maulat, C., Suc, B., & Muscari, F. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i21.881 · Cited by 47
Ni, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i45.17206 · Cited by 41
Cited by
Korean Liver Cancer Association, K., & National Cancer Center, N. (2019) · Gut and Liver · doi:10.5009/gnl19024 · Cited by 391
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0294 · Cited by 343
Syringic acid triggers reactive oxygen species–mediated cytotoxicity in HepG2 cells
Gheena, S., & Ezhilarasan, D. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119839173 · Cited by 323
Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview
Rashed, W. M., Kandeil, M. A. M., Mahmoud, M. O., & Ezzat, S. (2020) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-020-0016-x · Cited by 283
Xia, Y., Tang, W., Qian, X., Li, X., Cheng, F., Wang, K., Zhang, F., Zhang, C., Li, D., Song, J., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004656 · Cited by 228
Metadata
- Authors
- Hartke, J., Johnson, M., & Ghabril, M.
- Venue
- Seminars in Diagnostic Pathology
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 34
- Issue
- 2
- Pages
- 153-159
- ISSN
- 0740-2570 (ISSN-L)
- OpenAlex
- W2561456541
- Cited by
- 670
- References
- 98
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.